Sharp invests $21M to expand US packaging capacity and capabilities25 Apr 2019
New equipment installations will include vial labellers, as well as an HPV cold sterilization system.
Sharp has invested $21 million in expanding capacity and capabilities at its Allentown and Conshohocken Pennsylvania facilities.
The latest expansion in the Allentown campus includes a co-investment with one of Sharp’s clients and represents the third phase of development of its Biotechnology Center of Excellence. New equipment installations will include vial labellers as well as a Vaporized Hydrogen Peroxide (HPV) cold sterilization system.
Kevin Orfan, US President of Sharp Packaging said: “We are seeing increased demand for our packaging capabilities from clients across the biotech industry, with the injectables sector growing significantly in recent years.
“We are making these capacity expansions on behalf of our clients and through our parent UDG Healthcare. Sharp has invested continuously to keep pace with demand for our services. This expansion is intended to support that demand into the future.”
Building four in Sharp US’s Allentown Campus opened as the company’s Injectables Center of Excellence in April 2016. When the Allentown facility was built, it included an additional area of undeveloped space of approximately 21,500 sq ft.
Subsequent investment doubled Pre-filled Syringe (PFS), autoinjector and pen assembly and increased cold storage capacity at the site as part of the company’s drive to meet growing demand from the injectable device and biologics markets.
The company has invested significantly in its global facilities over recent years including $11 million on its new Clinical Services Centre of Excellence in Wales, an additional $11 million on enhancing its injectable and cold chain capabilities in the US, Belgium and the Netherlands and $23m on its recently refitted state-of-the-art facility in Bethlehem, PA.
Rick Seibert, Sr Vice President, Innovation and Technology Services at Sharp, will be delivering a Pharma Insight Briefing at CPhI North America, Chicago, Illinois, 30 April - 2 May 2019.
Thermo Fisher Scientific signs agreement with Lilly Oncology for companion diagnostic
10 Sep 2019
Strategic agreement utilizes FDA-approved next-generation sequencing Oncomine Dx Target Test to identify RET-altered NSCLC and thyroid cancer patients who may be suitable for Lilly's RET inhibitor.Read more
FUJIFILM Irvine Scientific launches BalanCD Gal Supplement for biotherapeutic development
10 Sep 2019
Delivers enhanced galactosylation for improved protein quality, and antibody binding and function.Read more
Drivers behind Saudi Arabia’s forecast 10.74 $billion 2022 market
9 Sep 2019
Growing population, increase in non-communicable diseases and major investment in new hospitals, clinics and treatments driving growth.Read more
Catalent to open new clinical supply facility in San Diego
6 Sep 2019
Will enhance speed to clinic through expanded early-phase clinical supply and oral dose development services.Read more
Take part in pharma’s largest reputation survey
6 Sep 2019
Use your voice to shape CPhI Worldwide's third annual global survey of the major trends, changes and developments in the industry.Read more
BioCity backs world's first Rx to OTC switch incubator
5 Sep 2019
Maxwellia considered to have the skills and the expertise to deliver and reach their goal of creating the big OTC brands of the future.Read more
Velesco Pharma to triple its clinical manufacturing capacity
4 Sep 2019
Company's new building in Wixom, MI replace and consolidate its existing manufacturing site in Kalamazoo, MI.Read more
Taiwan's biggest CDMO secures FDA approval
3 Sep 2019
Customers claim Bora's oral solid dosage Zhunan facility is in the top 5 external manufacturing facilities they’ve ever visited in the world.Read more
China relaxes import regulations to improve access and availability of affordable medicines
3 Sep 2019
The potential for generics to support the healthcare needs of China is significant.Read more
Dutch company receives €20 million for skin cancer diagnostic test
3 Sep 2019
The test can accurately predict the risk of having metastases present in the lymph nodes without having to undergo surgery to remove lymph nodes.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation